A Rash of Developments in Chronic Spontaneous Urticaria Treatment and Management
| Time Commitment: | 4 hours and 45 minutes over 6 weeks |
| Target Professions: | DO, MD, Nurse Practitioner, Physician Assistant |
| Target Specialties: | Allergy and Immunology, Dermatology |
| Credits Available: | 4.75 AMA PRA Category 1 Credits™ |
Chronic spontaneous urticaria (CSU) is a prevalent, potentially debilitating disease that can prove challenging to manage successfully. Although antihistamines, anti-IgE monoclonal antibodies, and off-label suppressants can alleviate recurrent hives and angioedema, many patients with CSU are refractory to treatments comprising the standard of care. These limitations have spurred the development and examination of novel agents, such as BTK inhibitors, in patients with inadequately controlled disease. Through this three-part, small-group educational program, allergists, dermatologists, and other ancillary clinicians can learn how to more effectively navigate the CSU differential diagnosis, select the most appropriate therapies, and address more challenging management scenarios tied to treatment de-escalation. In doing so, healthcare providers can ensure that the rash of therapeutic developments in CSU are used to their fullest potential.
CME/CE Accreditation Information
Itinerary
PART ONE
Answer the following questions to assess your knowledge of the diagnosis and treatment of patients with chronic spontaneous urticaria.
This first module is designed to enhance your familiarity with the defining characteristics of CSU.
This self-study module is designed to enhance your understanding of the pathophysiology mediating the development of CSU.
This module is designed to improve your ability to measure disease activity in CSU, define treatment success, de-escalate therapy in appropriate situations, and better coordinate care efforts with other members of the care team.
Answer the following questions to assess your gained knowledge of the diagnosis and treatment of patients with chronic spontaneous urticaria.
This live group discussion is centered around the educational content of the self-study modules that examined the differential diagnosis of CSU, emerging treatments, patient-reported outcomes, defining treatment success, treatment de-escalation, and strategies for multidisciplinary management.
PART TWO
This activity features a 28-year-old male who presents to your clinic today with symptoms of uncontrolled CSU.
This activity features a 60-year-old female who presents to your clinic today with symptoms of uncontrolled CSU.
In light of the information reviewed and discussed during this program, please share an action plan that you will implement to improve the diagnosis and management for your patients with chronic spontaneous urticaria (CSU).
This live group discussion is focused on the case studies found in the Group Challenges, which explore how to optimize the management of patients with CSU who are refractory to guideline-recommended antihistamines and anti-IgE therapies.
Interested in becoming a Group Leader?
Group leaders should be experts in the fields of allergy and immunology, dermatology, and chronic spontaneous urticaria. Apply Now
Interested in participating in this curriculum? You can join one of the following groups:
Jonathan Bernstein, MDProfessor
Maya Gharfeh, MD, MPHPhysician
Nicole Chase, MD, FAAP, FAAAAI, FACAAIASSOCIATE PROFESSOR
Physician
Medical Director
DO
Assistant Professor of Pediatrics
Srividya Sridhara, MDMD
Allergist
Clinical Fellow
Jacqueline Squire, MDDoctor
Physician/Assistant Clinical Professor
Doanh Nguyen, MDPhysician
